Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.42M Sell
9,444
-634
-6% -$217K 0.41% 54
2026
Q1
$3.55M Sell
10,078
-790
-7% -$282K 0.44% 53
2025
Q4
$3.56M Sell
10,868
-139
-1% -$44.1K 0.43% 53
2025
Q3
$3.11M Buy
11,007
+120
+1% +$34.8K 0.38% 59
2025
Q2
$3.04M Sell
10,887
-623
-5% -$176K 0.38% 60
2025
Q1
$3.59M Buy
11,510
+236
+2% +$69.7K 0.49% 58
2024
Q4
$2.94M Sell
11,274
-14
-0.1% -$4.15K 0.4% 59
2024
Q3
$3.64M Sell
11,288
-65
-0.6% -$21.3K 0.5% 55
2024
Q2
$3.55M Buy
11,353
+146
+1% +$42.9K 0.52% 52
2024
Q1
$3.19M Sell
11,207
-131
-1% -$38.3K 0.47% 59
2023
Q4
$3.27M Buy
11,338
+380
+3% +$104K 0.49% 58
2023
Q3
$2.95M Sell
10,958
-140
-1% -$34.9K 0.47% 54
2023
Q2
$2.46M Buy
11,098
+705
+7% +$164K 0.37% 62
2023
Q1
$2.51M Buy
10,393
+23
+0.2% +$5.65K 0.41% 59
2022
Q4
$2.72M Sell
10,370
-701
-6% -$188K 0.45% 58
2022
Q3
$2.5M Sell
11,071
-1,737
-14% -$421K 0.44% 56
2022
Q2
$3.12M Sell
12,808
-318
-2% -$77.9K 0.49% 53
2022
Q1
$3.17M Buy
13,126
+126
+1% +$28.9K 0.43% 58
2021
Q4
$2.92M Sell
13,000
-53
-0.4% -$11.2K 0.38% 63
2021
Q3
$2.78M Buy
13,053
+1,325
+11% +$305K 0.38% 65
2021
Q2
$2.86M Buy
11,728
+7,175
+158% +$1.77M 0.41% 63
2021
Q1
$1.13M Sell
4,553
-434
-9% -$104K 0.22% 67
2020
Q4
$1.15M Sell
4,987
-412
-8% -$95K 0.23% 63
2020
Q3
$1.37M Buy
+5,399
New +$1.34M 0.31% 56

Other funds holding AMGN

LaFleur & Godfrey's AMGN Position: Q2 2026 in Review

LaFleur & Godfrey reduced its Amgen (AMGN) stake by 6.3% in Q2 2026, selling an estimated $217K and leaving 9,444 shares worth $3.42M. The position accounts for 0.41% of the portfolio, ranked #54.

LaFleur & Godfrey first reported a position in AMGN in Q3 2020 and has held it in 24 quarters since. The position peaked at $3.64M in Q3 2024. 1,330 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • LaFleur & Godfrey held 9,444 shares of Amgen worth $3.42M as of Q2 2026.
  • LaFleur & Godfrey sold 634 Amgen shares in Q2 2026, an estimated $217K.
  • Amgen made up 0.41% of LaFleur & Godfrey's portfolio in Q2 2026, its #54 holding.
  • LaFleur & Godfrey first reported a position in Amgen in Q3 2020 and has held it in 24 quarters since.
  • LaFleur & Godfrey's Amgen position peaked at $3.64M in Q3 2024.
  • 1,330 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on LaFleur & Godfrey's 13F filing for Q2 2026, filed 15 Jul 2026.